BioMedix

Company Description

In construction industry we play an important role, given the quality of our ELISA kits,cytokines,chemokines,adhesion molecules,cancer research,apoptosis prevailing in the market. Our production facility was first launched with US$5 Million of initial capital and now takes care of Elisa Kits manufacturing with skilled workforce and technologically advanced equipment, as a reputable Manufacturer would do. In addition, we hold United Arab Emirates,India,South Korea,Thailand,Vietnam export share across borders, thanks to our aesthetically appealing and durable Elisa Kits. We are enlisted among top Supplier of Athens, Attiki, Greece, owing to our ELISA kits,cytokines,chemokines,adhesion molecules,cancer research,apoptosis, being top choice in the construction supplies market. BioMedix Private Limited has reached annual revenue scale across US$50 Million - US$100 Million, based on our successful 12 Years of export history. Our product range is specifically designed to level up architecture not only in terms of appeal but also a make that commits years of service. Since, 2008 our products have been remarkable helping us reach a quite fruitful export ratio value estimating around US$10 Million - US$50 Million.